scholarly journals California serogroup Gc (G1) glycoprotein is the principal determinant of pH-dependent cell fusion and entry

Virology ◽  
2005 ◽  
Vol 338 (1) ◽  
pp. 121-132 ◽  
Author(s):  
Matthew L. Plassmeyer ◽  
Samantha S. Soldan ◽  
Karen M. Stachelek ◽  
Julio Martín-García ◽  
Francisco González-Scarano
2017 ◽  
Vol 38 (2) ◽  
pp. 89-97 ◽  
Author(s):  
Yoshimi TSUDA ◽  
Manabu IGARASHI ◽  
Ryo ITO ◽  
Sanae NISHIO ◽  
Kenta SHIMIZU ◽  
...  

2018 ◽  
Vol 114 (3) ◽  
pp. 605a
Author(s):  
Ruben M. Markosyan ◽  
Mariana Marin ◽  
Fredric S. Cohen ◽  
Gregory B. Melikyan

2017 ◽  
Vol 70 (4) ◽  
pp. 388-393 ◽  
Author(s):  
Sanae Nishio ◽  
Yoshimi Tsuda ◽  
Ryo Ito ◽  
Kenta Shimizu ◽  
Kumiko Yoshimatsu ◽  
...  

1990 ◽  
Vol 52 (4) ◽  
pp. 839-841
Author(s):  
Eiichi HONDA ◽  
Hironori TAKAHASHI ◽  
Katsunori OKAZAKI ◽  
Tetsuo KUMAGAI

2005 ◽  
Vol 11 (1) ◽  
pp. 65-74 ◽  
Author(s):  
Changhua Ji ◽  
Jun Zhang ◽  
Nick Cammack ◽  
Surya Sankuratri

In the current study, a novel coreceptor-specific cell-cell fusion (CCF) assay system is reported. The system possesses the following features: dual CCR5-dependent and CXCR4-dependent CCF assays, all stable cell lines, inducible expression of gp160 to minimize cytotoxicity, robust luciferase reporter, and 384-well format. These assays have been validated using various known HIV entry inhibitors targeting various stages of the HIV entry/fusion process, including fusion inhibitors, gp120 inhibitors, CCR5 antagonists, CCR5 antibodies, and CXCR4 antagonists. IC 50data generated from this assay system were well correlated to that from the antiviral assays. The effects of DMSOon this assay systemwere assessed, and a 2-to 3-fold increase in luciferase activitywas observed in the presence of 0.05% to2% DMSO. Although cell-cell fusion efficiencywas enhanced, no changes in drug response kinetics for entry inhibitors were found in the presence of 0.1% or 0.5% DMSO. This assay system has been successfully used for the identification and characterization of thousands of CCR5 inhibitors.


1982 ◽  
Vol 26 (11) ◽  
pp. 1035-1043 ◽  
Author(s):  
Kazuaki Mannen ◽  
Masanobu Ohuchi ◽  
Kumato Mifune
Keyword(s):  

2006 ◽  
Vol 80 (7) ◽  
pp. 3180-3188 ◽  
Author(s):  
Victor C. Chu ◽  
Lisa J. McElroy ◽  
Vicky Chu ◽  
Beverley E. Bauman ◽  
Gary R. Whittaker

ABSTRACT Coronaviruses are the causative agents of respiratory disease in humans and animals, including severe acute respiratory syndrome. Fusion of coronaviruses is generally thought to occur at neutral pH, although there is also evidence for a role of acidic endosomes during entry of a variety of coronaviruses. Therefore, the molecular basis of coronavirus fusion during entry into host cells remains incompletely defined. Here, we examined coronavirus-cell fusion and entry employing the avian coronavirus infectious bronchitis virus (IBV). Virus entry into cells was inhibited by acidotropic bases and by other inhibitors of pH-dependent endocytosis. We carried out fluorescence-dequenching fusion assays of R18-labeled virions and show that for IBV, coronavirus-cell fusion occurs in a low-pH-dependent manner, with a half-maximal rate of fusion occurring at pH 5.5. Fusion was reduced, but still occurred, at lower temperatures (20°C). We observed no effect of inhibitors of endosomal proteases on the fusion event. These data are the first direct measure of virus-cell fusion for any coronavirus and demonstrate that the coronavirus IBV employs a direct, low-pH-dependent virus-cell fusion activation reaction. We further show that IBV was not inactivated, and fusion was unaffected, by prior exposure to pH 5.0 buffer. Virions also showed evidence of reversible conformational changes in their surface proteins, indicating that aspects of the fusion reaction may be reversible in nature.


PROTOPLASMA ◽  
2019 ◽  
Vol 256 (6) ◽  
pp. 1737-1751
Author(s):  
Alexey Eremin ◽  
Alexander A. Bulychev ◽  
Christopher Kluge ◽  
Jeremy Harbinson ◽  
Ilse Foissner

Sign in / Sign up

Export Citation Format

Share Document